Literature DB >> 17259861

S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis.

Alessandro Guidotti1, William Ruzicka, Dennis R Grayson, Marin Veldic, Graziano Pinna, John M Davis, Erminio Costa.   

Abstract

Prefrontal cortex (Brodmann's area 9) levels of the methyl donor S-adenosyl methionine were increased by about two-fold in schizophrenia and bipolar disorder patients, but not in unipolar depressed patients compared with nonpsychiatric subjects from the Stanley Foundation Neuropathology Consortium (Bethesda, Maryland, USA). Neither age, brain weight and pH, hemisphere, post-mortem interval, disease onset/duration, nor cumulative dose of fluphenazine affected S-adenosyl methionine content. In schizophrenia and bipolar disorder patients, the increase of S-adenosyl methionine is associated with an overexpression of DNA methyltransferase-1 mRNA in Brodmann's area 9 GABAergic neurons. Hence, the increased expression of S-adenosyl methionine and DNA methyltransferase-1 may contribute to promoter cytosine 5-methylation and to downregulation of the expression of mRNAs encoding for reelin and GAD67 in cortical GABAergic neurons of schizhophrenia and bipolar disorder patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259861     DOI: 10.1097/WNR.0b013e32800fefd7

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  40 in total

Review 1.  Epigenetic GABAergic targets in schizophrenia and bipolar disorder.

Authors:  A Guidotti; J Auta; Y Chen; J M Davis; E Dong; D P Gavin; D R Grayson; F Matrisciano; G Pinna; R Satta; R P Sharma; L Tremolizzo; P Tueting
Journal:  Neuropharmacology       Date:  2010-11-11       Impact factor: 5.250

2.  Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters.

Authors:  E Dong; A Guidotti; D R Grayson; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-07       Impact factor: 11.205

3.  Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection.

Authors:  Rajiv P Sharma; Dennis R Grayson; David P Gavin
Journal:  Schizophr Res       Date:  2007-10-24       Impact factor: 4.939

Review 4.  Histone modifications, DNA methylation, and schizophrenia.

Authors:  David P Gavin; Rajiv P Sharma
Journal:  Neurosci Biobehav Rev       Date:  2009-10-30       Impact factor: 8.989

Review 5.  Epigenetics of major psychosis: progress, problems and perspectives.

Authors:  Viviane Labrie; Shraddha Pai; Arturas Petronis
Journal:  Trends Genet       Date:  2012-05-21       Impact factor: 11.639

6.  Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures.

Authors:  David P Gavin; Cherise Rosen; Kayla Chase; Dennis R Grayson; Nguwah Tun; Rajiv P Sharma
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

Review 7.  The epigenome and postnatal environmental influences in psychotic disorders.

Authors:  Ehsan Pishva; Gunter Kenis; Daniel van den Hove; Klaus-Peter Lesch; Marco P M Boks; Jim van Os; Bart P F Rutten
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-19       Impact factor: 4.328

Review 8.  Diet and the epigenetic (re)programming of phenotypic differences in behavior.

Authors:  Patrick O McGowan; Michael J Meaney; Moshe Szyf
Journal:  Brain Res       Date:  2008-07-29       Impact factor: 3.252

Review 9.  Environmental influences on epigenetic profiles.

Authors:  Melissa A Suter; Kjersti M Aagaard-Tillery
Journal:  Semin Reprod Med       Date:  2009-08-26       Impact factor: 1.303

10.  An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes.

Authors:  A Zhubi; M Veldic; N V Puri; B Kadriu; H Caruncho; I Loza; H Sershen; A Lajtha; R C Smith; A Guidotti; J M Davis; E Costa
Journal:  Schizophr Res       Date:  2009-04-21       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.